IFNG and Hepatic fibrosis: All these data suggested that GZFL was able to ameliorate liver fibrosis in vitro and in vivo by modulating the crosstalk between TGF-β1/Smad2/3 and IFN-γ/STAT1/Smad7 signaling pathway via CUGBP1.